Mode
Text Size
Log in / Sign up
N/A Completed N=58 Prevention

Intensive Aerobic and Resistance Exercise Program (IAREP)

Type 2 Diabetes Mellitus · Mild Cognitive Impairment · Non-insulin-dependent Diabetes Mellitus · Cognitive Dysfunction
Source: ClinicalTrials.gov NCT06401733 ↗
Enrolled (actual)
58
Serious AEs
0.0%
Results posted
Feb 2026
Primary outcomePrimary: Change in Cognitive Function Based on Risk Stratification Score (RSS) — -0.2; -0.1; -0.8; 0.0 score on a scale

Summary

A 12-week Intensive Aerobic and Resistance Exercise Program (IAREP) intervention was implemented on high-risk and low-risk subjects with cognitive impairment in type 2 Diabetes Mellitus. The study aims to evaluate the effectiveness of IAREP on cognition, metabolic and inflammatory health, physical function, vascular health, and health practice behaviour in the Type 2 Diabetes Mellitus population (T2DM).

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Cognitive Function Based on Risk Stratification Score (RSS)
-0.2; -0.1; -0.8; 0.0 —
PRIMARY
Number of Participants With Change in Cognitive Function (Cognitive Impairment) Based on Vascular Dementia Battery (VDB)
10; 16; 8; 14 —
PRIMARY
Change in Cognitive Function Based on the Montreal Cognitive Assessment (MoCA)
25.0; 24.5; 25.0; 24.0 —
SECONDARY
Change in Metabolic Health
— —
SECONDARY
Change in Inflammatory Condition
— —
SECONDARY
Change in Short Physical Performance Battery (SPPB)
— —
SECONDARY
Change in Sarcopenia Risk
— —
SECONDARY
Change in Blood Pressure
— —
SECONDARY
Change in Physical Activity: International Physical Activity Questionnaire - Short Form
— —
SECONDARY
Change in Self-care of Diabetes Index (SCODI)
— —
SECONDARY
Change in Self-related and Health Practice (SRAHP)
— —

Eligibility Criteria

Inclusion Criteria

  • Aged 40 to 85
  • Living in the community
  • Diagnosed with type 2 diabetes mellitus (T2DM)
  • Literate in English or Mandarin
  • Activities of daily living (ADL)-independent
  • Obtain at least a score of 5 in short physical performance battery (SPPB) test

Exclusion criteria

  • Severe cognitive (e.g., dementia) or psychiatric disorders (e.g., schizophrenia or severe depression)
  • Severe hearing or vision impairments
  • Terminally ill medical conditions (e.g., end stage cancer), severe cardiovascular, respiratory (e.g., respiratory failure), or orthopedic conditions (e.g., freeze shoulder)
  • Absolute contraindications to aerobic exercise and resistance training programs (e.g., recent myocardial infarction or electrocardiography changes, complete heart block, acute congestive heart failure, unstable angina, uncontrolled hypertension)
  • Pregnant or breastfeeding women
  • Uncomfortable with video-recording of intervention sessions
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT06401733). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search